Department of Pathology, Copenhagen University Hospital Hvidovre, Kettegård Allé 30, 2650 Hvidovre, Copenhagen, Denmark.
Department of Laboratory Medicine, Karolinska Institutet, Stockholm 14186, Sweden.
Br J Cancer. 2018 Jan;118(1):138-144. doi: 10.1038/bjc.2017.371. Epub 2017 Nov 14.
Self-sampling for human papillomavirus (HPV) offered to women who do not participate in cervical cancer screening is an increasingly popular method to increase screening coverage. The rationale behind self-sampling is that unscreened women harbour a high proportion of undetected precancer lesions. Here, we compare the cervical intraepithelial neoplasia grade 2 or worse (⩾CIN2) detection rate between non-attenders who participated in self-sampling and women attending routine screening.
A total of 23 632 women who were qualified as non-attenders in the Copenhagen Region were invited for HPV-based self-sampling. Of these, 4824 women returned a self-sample, and HPV-positive women were referred for cytology and HPV co-testing as follow-up. The entire cohort and a reference cohort (3347 routinely screened women) were followed for histopathology confirmed ⩾CIN2. Odds ratio (OR) and the relative positive predictive value of ⩾CIN2 detection between the two populations were estimated.
Women participating in self-sampling had a higher ⩾CIN2 detection than women undergoing routine cytology-based screening (OR=1.83, 95% CI: 1.21-2.77) and a similar detection as routinely screened women tested with cytology and HPV testing (OR=1.03, 95% CI: 0.75-1.40). The positive predictive value for ⩾CIN2 was higher in screening non-attenders than in routinely HPV- and cytology-screened screened women (36.5% vs 25.6%, respectively).
Self-sampling offered to non-attenders showed higher detection rates for ⩾CIN2 than routine cytology-based screening, and similar detection rates as HPV and cytology co-testing. This reinforces the importance of self-sampling for screening non-attenders in organised cervical cancer screening.
向未参加宫颈癌筛查的女性提供人乳头瘤病毒(HPV)自我采样,是提高筛查覆盖率的一种越来越受欢迎的方法。自我采样的基本原理是,未筛查的女性存在大量未检测到的癌前病变。在这里,我们比较了参加自我采样的未就诊者和常规筛查女性的宫颈上皮内瘤变 2 级或更高级别(≥CIN2)检出率。
共有 23632 名符合哥本哈根地区未就诊条件的女性被邀请进行 HPV 自我采样。其中,4824 名女性回寄了自检样本,HPV 阳性的女性被转诊进行细胞学和 HPV 联合检测作为随访。整个队列和一个参考队列(3347 名常规筛查女性)都进行了组织病理学确诊的≥CIN2 随访。我们估计了两组人群中≥CIN2 检出的比值比(OR)和相对阳性预测值。
参加自我采样的女性≥CIN2 检出率高于接受常规基于细胞学筛查的女性(OR=1.83,95%CI:1.21-2.77),与接受细胞学和 HPV 联合检测的常规筛查女性(OR=1.03,95%CI:0.75-1.40)相似。筛查未就诊者的≥CIN2 阳性预测值高于常规 HPV 和细胞学筛查女性(分别为 36.5%和 25.6%)。
向未就诊者提供的自我采样在检测≥CIN2 方面的检出率高于常规基于细胞学的筛查,与 HPV 和细胞学联合检测的检出率相似。这进一步强调了自我采样在组织化宫颈癌筛查中对筛查未就诊者的重要性。